These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


715 related items for PubMed ID: 19247976

  • 1. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK, El-Din MS, Azmy E.
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [Abstract] [Full Text] [Related]

  • 2. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M, Noguera ME, Gisselbrecht C, Haddad A, Brice P, Marolleau JP, Soulier J, Mounier N.
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [Abstract] [Full Text] [Related]

  • 3. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
    Del Giudice I, Morilla A, Osuji N, Matutes E, Morilla R, Burford A, Maravelaki S, Owusu-Ankomah K, Swansbury J, A'Hern R, Brito-Babapulle V, Catovsky D.
    Cancer; 2005 Nov 15; 104(10):2124-32. PubMed ID: 16211545
    [Abstract] [Full Text] [Related]

  • 4. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E, Domingo-Clarós A, Gonzàlez-Barca E, Beneitez D, Alonso E, Romagosa V, De Sanjos S, Petit J, Grañena A, Fernández de Sevilla A.
    Haematologica; 2002 Oct 15; 87(10):1021-7. PubMed ID: 12368155
    [Abstract] [Full Text] [Related]

  • 5. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
    Cruse JM, Lewis RE, Webb RN, Sanders CM, Suggs JL.
    Exp Mol Pathol; 2007 Dec 15; 83(3):459-61. PubMed ID: 17931624
    [Abstract] [Full Text] [Related]

  • 6. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N, Salviat A, Boutet C, Arnoulet C, Durrieu F, Lenormand B, Leprêtre S, Olschwang S, Jardin F, Lafage-Pochitaloff M, Penther D, Sainty D, Reminieras L, Feuillard J, Béné MC, GEIL.
    Haematologica; 2008 Feb 15; 93(2):215-23. PubMed ID: 18223290
    [Abstract] [Full Text] [Related]

  • 7. Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
    Eisele L, Haddad T, Sellmann L, Dührsen U, Dürig J.
    Leuk Res; 2009 Jun 15; 33(6):775-8. PubMed ID: 18922578
    [Abstract] [Full Text] [Related]

  • 8. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Shamsian Khoramabadi A, Rabbani H, Shokri F.
    Iran J Immunol; 2008 Mar 15; 5(1):25-35. PubMed ID: 18319522
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
    D'Arena G, Tarnani M, Rumi C, Vaisitti T, Aydin S, De Filippi R, Perrone F, Pinto A, Chiusolo P, Deaglio S, Malavasi F, Laurenti L.
    Am J Hematol; 2007 Sep 15; 82(9):787-91. PubMed ID: 17534928
    [Abstract] [Full Text] [Related]

  • 10. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A, Klein-Hitpass L, Thomale J, Deenen R, Carpinteiro A, Nückel H, Ebeling P, Führer A, Edelmann J, Sellmann L, Dührsen U, Dürig J.
    Leukemia; 2006 Oct 15; 20(10):1774-82. PubMed ID: 16932341
    [Abstract] [Full Text] [Related]

  • 11. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression.
    Boonstra JG, van Lom K, Langerak AW, Graveland WJ, Valk PJ, Kraan J, van 't Veer MB, Gratama JW.
    Cytometry B Clin Cytom; 2006 May 15; 70(3):136-41. PubMed ID: 16568475
    [Abstract] [Full Text] [Related]

  • 12. Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia.
    Röth A, de Beer D, Nückel H, Sellmann L, Dührsen U, Dürig J, Baerlocher GM.
    Br J Haematol; 2008 Nov 15; 143(3):383-6. PubMed ID: 18759763
    [Abstract] [Full Text] [Related]

  • 13. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
    Zucchetto A, Bomben R, Dal Bo M, Sonego P, Nanni P, Rupolo M, Bulian P, Dal Maso L, Del Poeta G, Del Principe MI, Degan M, Gattei V.
    J Cell Physiol; 2006 May 15; 207(2):354-63. PubMed ID: 16331666
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.
    Cancer; 2003 Apr 15; 97(8):1914-9. PubMed ID: 12673718
    [Abstract] [Full Text] [Related]

  • 16. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E.
    N Engl J Med; 2003 May 01; 348(18):1764-75. PubMed ID: 12724482
    [Abstract] [Full Text] [Related]

  • 17. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
    Catherwood MA, Matthews C, Niblock R, Dobbin E, Morris TC, Alexander HD.
    Eur J Haematol; 2006 Apr 01; 76(4):294-8. PubMed ID: 16519700
    [Abstract] [Full Text] [Related]

  • 18. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L, Lasa A, Carricondo MT, Hernández C, Ubeda J, Nomdedéu JF.
    Cytometry B Clin Cytom; 2007 Mar 01; 72(2):96-102. PubMed ID: 17051526
    [Abstract] [Full Text] [Related]

  • 19. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
    Gentile M, Mauro FR, Calabrese E, De Propris MS, Giammartini E, Mancini F, Milani ML, Guarini A, Foà R.
    Br J Haematol; 2005 Aug 01; 130(4):549-57. PubMed ID: 16098069
    [Abstract] [Full Text] [Related]

  • 20. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA, Craig FE, Swerdlow SH.
    Hum Pathol; 2006 Feb 01; 37(2):152-9. PubMed ID: 16426914
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.